venBio Select Advisor »

Adverum Biotechnologies shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Adverum Biotechnologies (ADVM) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Adverum Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Adverum Biotechnologies held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adverum Biotechnologies by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.9M 417k 14.14

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Apellis Pharmaceuticals Common (APLS)
Ascendis Pharma Sponsored ADR (ASND)
Sarepta Therapeutics Common (SRPT)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Spdr Series Trust - S&p Biotech Etf (XBI)
Biomarin Pharmaceutical Common (BMRN)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Viking Therapeutics Common (VKTX)
Arrowhead Pharmaceuticals Common (ARWR)
Xenon Pharmaceuticals Common (XENE)
Alpine Immune Sciences Common

View all positions for venBio Select Advisor

Top funds holding Adverum Biotechnologies

BML Capital Management
Franklin Resources
BlackRock
VR Adviser
BlackRock
Frazier Life Sciences Management
Vanguard Group
5AM Venture Management
Geode Capital Management
Logos Global Management
Goldman Sachs Group
Pale Fire Capital SE
State Street Corporation
Dimensional Fund Advisors
Northern Trust

View all funds holding Adverum Biotechnologies